Obesity-hypoventilation in Metabolic Syndrom Patients
- Conditions
- Metabolic SyndromeObesity Hypoventilation SyndromeCapnography
- Registration Number
- NCT04839419
- Lead Sponsor
- SOS Oxygene Mediterranee
- Brief Summary
The purpose of the study is to determined the prevalence of obesity-hypoventilation syndrome in patients with metabolic syndrom.
- Detailed Description
After being informed about the study and potential risks, patient agreed to participate and undergo :
a functional respiratory exploration, an arterial blood gas analyze, and a polygraphy coupled with a capnography during the same night.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
- BMI>30 kg/m2
- no treatment with CPAP nor NIV
- obstructive respiratory disease
- non-treated cardiac dysfunction
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Arterial pression in CO2 At the inclusion PaCO2
Capnia Up to one mont after inclusion Arterial pression in CO2 and transcutaneous pression in CO2
- Secondary Outcome Measures
Name Time Method Arterial pression in oxygen At the inclusion PaO2
obstructive sleep apnea items Up to one mont after inclusion Apnea-hypopnea index
Hemoglobin At the inclusion Hb
somnolence At the inclusion EPWORTH questionnaire; Minimum = 0; Maximum = 24, Higher score means a worth outcome
Physical activity level At the inclusion Ricci\&Gagnon questionnaire, Minimum = 9; Maximum = 45, Higher score means a worth outcome
BMI At the inclusion body mass index
Arterial blood bicarbonates At the inclusion HCO3-
Arterial blood gases At the inclusion pH
Night Oxygen saturation Up to one mont after inclusion SpO2
Trial Locations
- Locations (1)
Clinique du Château de Vernhes
🇫🇷Bondigoux, France